Castillón, Jaume Capdevila http://orcid.org/0000-0003-0718-8619
Gordoa, Teresa Alonso
Bayonas, Alberto Carmona
Carretero, Ana Custodio
García-Carbonero, Rocío
Pulido, Enrique Grande
Fonseca, Paula Jiménez
Lete, Angela Lamarca
Huerta, Angel Segura
Plazas, Javier Gallego
Article History
Received: 18 April 2023
Accepted: 20 April 2023
First Online: 19 May 2023
Declarations
:
: JCC report Advisory Board from Ipsen, Exelisis, Bayer, Eisai, Advanced Accelerator Applications, Amgen, Lilly, Huchmed, ITM, Merck Serono, Roche and Esteve; Speaker from Ipsen, Exelisis, Eisai, Advanced Accelerator Applications, Lilly, Huchmed, ITM, Roche, Esteve and Advanz; Grant from Bayer, Eisai, Advanced Accelerator Applications, and Amgen. TAG report Advisory Board from IPSEN, Lilly, Advanced Accelerator Applications, Bayer, Roche, Pfizer, Janssen, Sanofi, Astellas, Eisai, BMS, MSD, and Novartis; Speaker from IPSEN, Lilly, Advanced Accelerator Applications, Bayer, Astellas and Eisai; Grant from IPSEN and Janssen. ACB reports Advisory Board from Adacap; Spaker from Ipsen Spain. RGC report Advisory Board from AAA, Advanz Pharma, Amgen, Bayer, BMS, Boerhringer, Esteve, Hutchmed, Ipsen, Merck, Midatech Pharma, MSD, Novartis, PharmaMar, Pierre Fabre, Roche, and Servier; Speaker from AAA, Advanz Pharma, Amgen, Bayer, BMS, Boerhringer, Esteve, Hutchmed, Ipsen, Merck, Midatech Pharma, MSD, Novartis, PharmaMar, Pierre Fabre, Roche, and Servier; Personal Feels from AAA, Advanz Pharma, Amgen, Bayer, BMS, Boerhringer, Esteve, Hutchmed, Ipsen, Merck, Midatech Pharma, MSD, Novartis, PharmaMar, Pierre Fabre, Roche, and Servier; Grant from Pfizer, BMS, and MSD. EGP report Advisory Board from Advanced Accelerator Applications, AstraZeneca, Bristol Myers Squibb, Eisai, Esteve, Ipsen, Janssen, Lexicon, Lilly, Merck KGaA, and Pfizer; Speaker from Advanced Accelerator Applications, AstraZeneca, Bayer, Bristol Myers Squibb, Eisai, Ipsen, Janssen, Lexicon, Lilly, Merck KGaA, and Pfizer; Grant from Astellas, AstraZeneca, Ipsen, ITM-Radiopharma, Merck KGaA, and Pfizer. ALL report Travel and educational support from Ipsen, Pfizer, Bayer, AAA, SirtEx, Novartis, Mylan, and Delcath; Speaker honoraria from Merck, Pfizer, Ipsen, Incyte, AAA, QED, Servier, Astra Zeneca, EISAI, Roche, and Advanz Pharma; Advisory and consultancy honoraria from EISAI, Nutricia Ipsen, QED, Roche, Servier, Boston Scientific, Albireo Pharma, AstraZeneca, Boehringer Ingelheim, GENFIT, TransThera Biosciences, and Taiho; Member of the Knowledge Network and NETConnect Initiatives funded by Ipsen. JGP report Advisory Board from AAA, Ipsen, Esteve, BMS, MSD, and Pierre Fabre; Speaker from AAA, Ipsen, and BMS. ACC, PJF, and ASH have nothing to disclose.
: The current study has been performed in accordance with the ethical standards laid down in the 1964 Declaration of Helsinki and its later amendments.
: Not applicable.